*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
D075 - Carcinoma in situ of prostate - as a primary diagnosis code | D075 - Carcinoma in situ of prostate - as a primary or secondary diagnosis code | |
---|---|---|
OUTCOMES | ||
Avg. LOS | 5.97 | |
Readmission Rate (%) | 18.46 | |
Unplanned Readmission Rate (%) | NA | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|
Total Hospitalizations at DRG | 41,026 |
Total Hospitalizations with ICD D075 - Carcinoma in situ of prostate | 14 |
DRG Share of Total Hospitalizations | 0.12 |
% of Total ICD D075 - Carcinoma in situ of prostate in DRG | 43.75 |
Avg LOS at DRG | 1.47 |
Avg LOS with ICD D075 - Carcinoma in situ of prostate | 1.79 |
Readmission Rate at DRG | 4.09 |
Readmission Rate with ICD D075 - Carcinoma in situ of prostate | NA |
Unplanned Readmission Rate at DRG | 3.2 |
Unplanned Readmission Rate with ICD D075 - Carcinoma in situ of prostate | NA |
Total Medicare payments at DRG | $301,816,837 |
Total Medicare payments with ICD D075 - Carcinoma in situ of prostate | $124,529 |
Total Medicare payment per Day at DRG | $5,001 |
Total Medicare payment per Day with ICD D075 - Carcinoma in situ of prostate | $4,981 |
Total Medicare payment per Hospitalization at DRG | $7,357 |
Total Medicare payment per Hospitalization with ICD D075 - Carcinoma in situ of prostate | $8,895 |
Total Medicare Charges at DRG | $2,330,115,586 |
Total Medicare Charges with ICD D075 - Carcinoma in situ of prostate | $1,311,645 |
Avg Charges at DRG | $56,796 |
Avg Charges with ICD D075 - Carcinoma in situ of prostate | $93,689 |
Mortality Rate at DRG | NA |
Mortality Rate with ICD D075 - Carcinoma in situ of prostate | NA |
SNF Discharge Rate at DRG | 0.28 |
SNF Discharge Rate with ICD D075 - Carcinoma in situ of prostate | NA |
Home Discharge Rate at DRG | 95.0 |
Home Discharge Rate with ICD D075 - Carcinoma in situ of prostate | 92.86 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 707: MAJOR MALE PELVIC PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 13,513 | ||||
Total Hospitalizations with ICD D075 - Carcinoma in situ of prostate | 27 | ||||
DRG Share of Total Hospitalizations | 0.04 | ||||
% of Total ICD D075 - Carcinoma in situ of prostate in DRG | 5.4 | ||||
Avg LOS at DRG | 7.02 | ||||
Avg LOS with ICD D075 - Carcinoma in situ of prostate | 7.22 | ||||
Readmission Rate at DRG | 26.89 | ||||
Readmission Rate with ICD D075 - Carcinoma in situ of prostate | NA | ||||
Unplanned Readmission Rate at DRG | 18.36 | ||||
Unplanned Readmission Rate with ICD D075 - Carcinoma in situ of prostate | NA | ||||
Total Medicare payments at DRG | $270,065,366 | ||||
Total Medicare payments with ICD D075 - Carcinoma in situ of prostate | $595,032 | ||||
Total Medicare payment per Day at DRG | $2,848 | ||||
Total Medicare payment per Day with ICD D075 - Carcinoma in situ of prostate | $3,051 | ||||
Total Medicare payment per Hospitalization at DRG | $19,986 | ||||
Total Medicare payment per Hospitalization with ICD D075 - Carcinoma in situ of prostate | $22,038 | ||||
Total Medicare Charges at DRG | $1,412,381,149 | ||||
Total Medicare Charges with ICD D075 - Carcinoma in situ of prostate | $3,047,228 | ||||
Avg Charges at DRG | $104,520 | ||||
Avg Charges with ICD D075 - Carcinoma in situ of prostate | $112,860 | ||||
Mortality Rate at DRG | 0.21 | ||||
Mortality Rate with ICD D075 - Carcinoma in situ of prostate | NA | ||||
SNF Discharge Rate at DRG | 15.04 | ||||
SNF Discharge Rate with ICD D075 - Carcinoma in situ of prostate | NA | ||||
Home Discharge Rate at DRG | 33.15 | ||||
Home Discharge Rate with ICD D075 - Carcinoma in situ of prostate | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 655: MAJOR BLADDER PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|
Total Hospitalizations at DRG | 499,133 | ||
Total Hospitalizations with ICD D075 - Carcinoma in situ of prostate | 13 | ||
DRG Share of Total Hospitalizations | 1.52 | ||
% of Total ICD D075 - Carcinoma in situ of prostate in DRG | 2.6 | ||
Avg LOS at DRG | 4.34 | ||
Avg LOS with ICD D075 - Carcinoma in situ of prostate | 5.0 | ||
Readmission Rate at DRG | 17.57 | ||
Readmission Rate with ICD D075 - Carcinoma in situ of prostate | NA | ||
Unplanned Readmission Rate at DRG | 12.56 | ||
Unplanned Readmission Rate with ICD D075 - Carcinoma in situ of prostate | NA | ||
Total Medicare payments at DRG | $3,254,711,780 | ||
Total Medicare payments with ICD D075 - Carcinoma in situ of prostate | $83,207 | ||
Total Medicare payment per Day at DRG | $1,504 | ||
Total Medicare payment per Day with ICD D075 - Carcinoma in situ of prostate | $1,280 | ||
Total Medicare payment per Hospitalization at DRG | $6,521 | ||
Total Medicare payment per Hospitalization with ICD D075 - Carcinoma in situ of prostate | $6,401 | ||
Total Medicare Charges at DRG | $16,863,396,143 | ||
Total Medicare Charges with ICD D075 - Carcinoma in situ of prostate | $431,902 | ||
Avg Charges at DRG | $33,785 | ||
Avg Charges with ICD D075 - Carcinoma in situ of prostate | $33,223 | ||
Mortality Rate at DRG | 1.33 | ||
Mortality Rate with ICD D075 - Carcinoma in situ of prostate | NA | ||
SNF Discharge Rate at DRG | 19.89 | ||
SNF Discharge Rate with ICD D075 - Carcinoma in situ of prostate | NA | ||
Home Discharge Rate at DRG | 49.27 | ||
Home Discharge Rate with ICD D075 - Carcinoma in situ of prostate | NA |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 14 |